Drawing for RHINOMEL MANUKA+

USPTO serial 79302993

RHINOMEL MANUKA+

Reviewed by CopyMark Law Group

Status 774
Filing date
Status date
Registration date
Examiner
CASE, LEIGH CAROLINE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RHINOMEL MANUKA+?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparation for the respiratory tract, for the prevention of diseases; pharmaceutical preparation for the respiratory tract, for the treatment of diseases, all of the foregoing containing honey sourced from the flower of the L. Scoparium tree originating from all regions, including Australia and New ZealandACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 26, 2025RFNTREFUSAL PROCESSED BY IB
Apr 4, 2025ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Apr 3, 2025OP.IOPPOSITION INSTITUTED NO. 999999
Mar 31, 2025OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Mar 29, 2025OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED
Feb 20, 2025ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Jan 28, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 28, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 22, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 2, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 13, 2024RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 28, 2023RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 14, 2023RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 8, 2022RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 18, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 12, 2022DOCKASSIGNED TO EXAMINER
Jun 29, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 29, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 4, 2022RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 10, 2021GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 10, 2021GNSLLETTER OF SUSPENSION E-MAILED
Sep 10, 2021CNSLSUSPENSION LETTER WRITTEN
Aug 20, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 20, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 20, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 22, 2021RFNTREFUSAL PROCESSED BY IB
Feb 27, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 27, 2021RFRRREFUSAL PROCESSED BY MPU
Feb 26, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 25, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 18, 2021DOCKASSIGNED TO EXAMINER
Feb 16, 2021DOCKASSIGNED TO EXAMINER
Feb 2, 2021MAFRAPPLICATION FILING RECEIPT MAILED
Jan 29, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 28, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance